SGO Issues May 5, 2016

sgo-issues

SGO Issues May 5, 2016

SGO congratulates new and transitioning members
Voices: Using teamwork to combat the bleomycin shortage | B.J. Rimel, MD
Gynecologic Oncology, May 2016
Foundation for Women’s Cancer 2016 Survivors Courses
2016 SGO Annual Meeting photos now on Flickr

SGO congratulates new and transitioning members

Since January, 53 new members joined the Society of Gynecologic Oncology and another 30 members transitioned to the next membership level. SGO congratulates the following new and transitioning members:

Transitioning Full Members
Saketh Ram Guntupalli, MD
Emily Ko, MD
Shannon Diane MacLaughlan, MD
Joseph Soon-Yau Ng, MD
Barbara Norquist, MD
Emma Rossi, MBBS
Ghadir Salame, MD

Transitioning Candidate Members
Joseph de la Garza
Diana P. English
Katherine M. Esselen, MD
Sarah Kay Goodrich, MD
Michael Stephen Guy, MD
Andrea D. Jewell, MD
Carolyn Lefkowits, MD
Ken Y. Lin, MD
Kristopher Shawn LyBarger, MD
Charlotte S. Marcus, MD
Fernanda Musa, MD
Susan Park, MD
Stephanie Ricci, MD
Katherine Tierney, MD
Behrounz Zand, MD, MS

Transitioning Fellow-in-Training Members
Robert Neff, MD
Krista Pfaendler, MD
Marian Symmes Johnson, MD
Ketura Preya Ann Wisner, MD

Transitioning International Member
Yfat Kadan, MD

Transitioning Senior Members
Linda Morgan, MD
Charles H. Pippitt, MD
Robert R. Taylor, MD

New Full Members
Georges I. Chamoun, DO
Ivy A. Petersen, MD
Michael Burton Dillon, MD
Lana de Souza Lawrence, MD
Huyen Pham, MD

New International Members
Deraldo Fernando Falcao Filho, MD
Yasser Diab, MD
Takayuki Enomoto, MD
Limor Helpman, MD
Jacob Korach, MD
Nadia P. Srur Rivero, MD

New Allied Members
Lisa Marie Babayan, PA-C
Candice Fori, PA-C
Betty Luu, PharmD
Callan L. Kosnik, PA-C
Mary Lucy Mattei, MSN
Jennifer Wold, PA-C

New Fellow-in-Training Members
R. Shae Connor, MD
Marcus Vinicius Silva Araujo Gurgel, MD
Kari Hacker, MD
Sharon Robertson, MD
Amanda Shepherd, MD
MaryAnn Wilbur

New Resident/Student Members
Courtney Bailey, DO
Dominique Michelle Barnes, MD
Rikki Desiree Baldwin, DO
Caithlin Baptists, MD
Christina Hunter Chapman, MD
Lindsey Charo, MD
Lauren Cooper, MD
Kalie Deutsch, MS
Lauren Dockery, MD
Christine Fitzsimmons, MD
Whitney Goldsberry, MD
Allison Gockley, MD
Margaret Griffith, MD
Claire Hoppenot, MD
Soledad Jorge, MD
Martha B. Kole, MD
Isabel M. Lazo, MD
Sarah K. Lynam, MD
Leah Marsh, MS
Theofano Orfanelli, MD
Sonali S. Patankar, MD
Yael Raz, MD
Blerina Salman, MD
Brandon Sawyer, MD
Brentley Smith, MD
Aaron Varghese, MD
Zachary Weber, Student
Juliet Wolford, MD
Jennifer Wong, MS4
Shih-Ern Yao, MD

Voices: Using teamwork to combat the bleomycin shortage | B.J. Rimel, MD

B.J. Rimel, MD

B.J. Rimel, MD

Two weeks ago my partner, Dr. Andrew Li, operated on a very young woman with a stage IV yolk sac tumor. We had discussed the chemotherapy regimen to give her and discussed the standard treatment of bleomycin, etoposide and cisplatin. Two days later we received and email from our pharmacy: “There is a national supply shortage of bleomycin. There is not enough drug at this hospital to start any new patients on regimens that contain this drug.”

Don’t get me wrong, we have a great pharmacy here at Cedars-Sinai Medical Center and they are always watching out for us. But we’ve had a few more rare tumors this year and we simply don’t have enough drug right now. Dr. Li emailed me “What do I do for my patient?” My response was pretty weak. “Call the pharmacist, see if she’s on the list of people they were already counting on. If not, we can call around and see if someone else can help?”

I didn’t really think this would work.

But it did.

Dr. Li wrote an email sent to every gynecologic oncologist in the LA County area he knew and asked, “I have this patient who needs bleomycin. Can anyone help?”

His first email back was from Dr. Christine Holschneider at Olive View-UCLA Medical Center. She said, “Give me some more information. Let me see what I can do.” The next response was from Dr. Joshua Cohen at UCLA Westwood who was also willing to help, followed by Dr. Yevgenia Ioffe at Loma Linda. Ultimately Dr. Ioffe was able to secure the total amount of bleomycin for this patient and is going to treat her.

This is not “can I borrow a cup of sugar.” This is a big, messy, complicated, time-consuming activity for any of these doctors and their teams–especially for a patient they have never met. It’s also heartwarming, amazing, and something that goes deeper than a drug shortage.

This story made me think about how our most powerful tool in the care of our patients is often each other. I often think that I am simply the product of those who have gone before me and taught me to be a gynecologic oncologist either through hands-on fellowship training or through their work in science or clinical trials. A day does not go by that I don’t text or phone a gynecologic oncology buddy and ask a question about how to treat a particular patient or how to fix a surgical issue.

We are a small and fairly close knit group. Now as we have a shortage of a medicine that is critical to our patients with rare germ cell tumors I see another avenue to use our Society, our friends, to help us care for our patients. I encourage you to reach out to your gynecologic oncology colleagues if you have patients who need this medication. And write to your congressperson about working to end drug shortages, like this one, in the future. If you don’t have many gynecologic oncology friends–call me! I encourage you to consider social media to make contact (not to discuss patient related information) using the hashtag #bleomycin.

Gynecologic Oncology, May 2016

Gynecologic Oncology May 2016, Volume 141, Issue 2, p189-402

Lead Article: Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer Callie M. Cox Bauer, Danielle M. Greer, Jessica J.F. Kram, Scott A. Kamelle

Editorial: Refining the Definition of Low-Risk Endometrial Cancer: Improving Value Jamie N. Bakkum-Gamez

Foundation for Women’s Cancer 2016 Survivors Courses

The Foundation for Women’s Cancer has confirmed three Ovarian Cancer Survivor Courses through fall of 2016: May 21 in New York, NY; Sept. 10 in Duarte, CA; and Nov. 5 in Washington, DC, in association with the National Race to End Women’s Cancer. The 2016 Survivors Course Schedule includes brochures and registration information, and will be updated throughout the year as additional courses are scheduled.

2016 SGO Annual Meeting photos now on Flickr

Photos from the 2016 SGO Annual Meeting in San Diego have been uploaded to SGO’s Flickr account. To inquire about additional photos that may be available or to request full resolution copies of photos on the Flickr account, contact Robyn Kurth at robyn.kurth@sgo.org.